John Radak, Paul Landers, Matthew Robin, Carl Severinghaus, Thomas Bachmann | GenomeWeb
Point-of-care diagnostics maker Quidel announced this week that John Radak has been named CFO of the firm, succeeding Paul Landers. Radak joins Quidel from Invitrogen, where he served as vice president and chief accounting officer since 2003.
 

 
Swiss compounds research company Tecan last month said its board of directors has appointed and  to its group executive committee.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.